AWARDDEFINITIVE CONTRACTSmall business
Definitive contract HHSN272201800011CHUMANETICS CORPORATION
Overview
Award facts
- Net obligations
- $10.30M
- $10,299,171of $10.30M potential value
- Outlays (paid to date)
- $5.35M
- $5.35M paid of $10.30M obligated$5,353,775
- Period of performance
- Mar 29, 2018 to Sep 30, 2025
- Ended
- Modifications
- 20
- Latest action Mar 3, 2025
- Contract type
- Definitive contract
- PIID HHSN272201800011C
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
IGF::OT::IGF AN NHP EFFICACY STUDY OF BIO 300 FOR MITIGATOR FOR DEARE-INDUCED PNEUMONITIS AND PULMONARY FIBROSIS
Dates and value
- Award date
- Signed on Mar 29, 2018
- Potential end of performance
- Sep 29, 2025
- Current value
- $10,299,171Base and exercised options
- Potential value (if all options are exercised)
- $10,299,171
Obligations by fiscal year of action
- FY2023: -$7 (de-obligation)
- FY2021: $1,872,652
- FY2020: $4,474,387
- FY2019: $2,179,037
- FY2018: $1,773,102
Total across 5 fiscal years: $10,299,171
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Mar 3, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationEDINA, MN
UEIMSRQYLLQLYQ5
CAGE code4B2E0
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyHUMANETICS CORPORATION
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885); Nih office of the director (0846)Program activities075-0846, 075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Minneapolis, Hennepin County, Minnesota 55435-6012
- Congressional district (place of performance)
- MN-03As reported at the time of the action
Classification and competition
Classification
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 12
Solicitation and notices
- Solicitation ID
- HHSNIHNIAIDBAA20171(as reported)
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- An nhp efficacy study of bio 300 for mitigator for deare-induced pneumonitis and pulmonary fibrosis
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Mar 29, 2018Base obligation at award: $1,773,102
- Latest action
- Mar 3, 2025 — Other administrative actionModification P00020; administrative: no change in scope or value
- Latest substantive action
- Apr 23, 2021 — Option exercisedModification P00013; obligation change +$1,872,652
- Latest funding action
- Apr 5, 2023 — Funding onlyModification P00018; obligation change -$7; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Other administrative action13
- Option exercised3
- Supplemental agreement (within scope)2
- Funding only1
- Change order1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 21
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2018/2018-0846-000
- 075-2019/2019-0846-000
- 075-2020/2020-0846-000
- 075-2020/2024-0885-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- L: Emergency P.L. 116-123
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
- COVID-19 supplemental obligations
- $4,513,701
- COVID-19 supplemental outlays
- $4,513,701